Skip to main content
Clinical Trials/NCT03104881
NCT03104881
Completed
Not Applicable

Comparisons of Two Types of Rehabilitation Robot for Upper Extremities: 3 Dimension Exoskeleton Type Upper Extremity Robot vs. 2 Dimension End-effector Type Robot): Randomized Controlled Trial

National Rehabilitation Center, Seoul, Korea1 site in 1 country40 target enrollmentApril 2015
ConditionsStroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
National Rehabilitation Center, Seoul, Korea
Enrollment
40
Locations
1
Primary Endpoint
Change of Fugl-Meyer Assessment
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Comparisons of two types of rehabilitation robot for upper extremities: 3 dimension exoskeleton type upper extremity robot vs. 2 dimension end-effector type robot)

Registry
clinicaltrials.gov
Start Date
April 2015
End Date
March 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
National Rehabilitation Center, Seoul, Korea
Responsible Party
Principal Investigator
Principal Investigator

Joon-Ho Shin

Team manager

National Rehabilitation Center, Seoul, Korea

Eligibility Criteria

Inclusion Criteria

  • Hemiplegic patients secondary to first cerebrovascular accidents
  • Onset ≥ 3 months
  • 8 ≤ Fugl-Meyer Assessment score ≤ 30
  • Shoulder or elbow flexor spasticity modified ashworth scale ≤ 3
  • Cognitively intact enough to understand and follow the instructions from the investigator

Exclusion Criteria

  • History of surgery of affected upper limb
  • Fracture of affected upper limb

Outcomes

Primary Outcomes

Change of Fugl-Meyer Assessment

Time Frame: Fugl-Meyer Assessment change from baseline at 4 weeks

Wolf motor function test

Time Frame: Fugl-Meyer Assessment change from baseline at 4 weeks

Secondary Outcomes

  • Motor status score(baseline, 4 weeks after baseline, 8 weeks after baseline, 10 weeks after baseline)
  • Pain of upper extremity(from baseline to 4 weeks after baseline)
  • Reach Error(baseline, 4 weeks after baseline, 8 weeks after baseline, 10 weeks after baseline)
  • Path Error(baseline, 4 weeks after baseline, 8 weeks after baseline, 10 weeks after baseline)
  • Mean velocity(baseline, 4 weeks after baseline, 8 weeks after baseline, 10 weeks after baseline)
  • Cricle size(baseline, 4 weeks after baseline, 8 weeks after baseline, 10 weeks after baseline)
  • Beck depression index(baseline, 4 weeks after baseline, 8 weeks after baseline, 10 weeks after baseline)
  • Wolf motor function test(baseline, 4 weeks after baseline, 8 weeks after baseline, 10 weeks after baseline)
  • medical research council scale of upper extremity(baseline)
  • Modified Ashworth scale of upeer extremity(baseline)
  • Stroke impact scale(baseline, 4 weeks after baseline, 8 weeks after baseline, 10 weeks after baseline)
  • Smoothness(baseline, 4 weeks after baseline, 8 weeks after baseline, 10 weeks after baseline)
  • Maximum velocity(baseline, 4 weeks after baseline, 8 weeks after baseline, 10 weeks after baseline)
  • Cricle independence(baseline, 4 weeks after baseline, 8 weeks after baseline, 10 weeks after baseline)
  • Intrinsic motivation inventory(4 weeks after baseline)
  • stroke rehabilitation motivation scale(baseline, 4 weeks after baseline, 8 weeks after baseline, 10 weeks after baseline)

Study Sites (1)

Loading locations...

Similar Trials